Proneurogenic Actions of FSH During Directed Differentiation of Neural Stem and Progenitor Cells from Ovarian Cortical Cells Towards the Dopaminergic Pathway

dc.contributor.authorGonzález Gil, Alfredo
dc.contributor.authorRojo Salvador, Concepción
dc.contributor.authorRamírez Gómez, Esther
dc.contributor.authorMartín Herranz, Ricardo
dc.contributor.authorSuárez Pinilla, Alberto Samuel
dc.contributor.authorOvalle Andreu, Susana
dc.contributor.authorRamos-Ruiz, Ricardo
dc.contributor.authorPicazo González, Rosa Ana
dc.date.accessioned2025-07-22T11:50:16Z
dc.date.available2025-07-22T11:50:16Z
dc.date.issued2025
dc.description.abstractExploring the neurogenic potential of extraneural stem cells under the actions of pro-neurogenic biomolecules may enhance the success of autologous cell therapy for neurodegenerative diseases such as Parkinson's. Neural stem and progenitor cells (NSPCs) from extraneural tissues have emerged as potential sources of functional dopaminergic (DA) neurons. Back-ground/Objectives: This study aimed to generate DA neurons from ovarian cortical cells (OCC)-derived NSPCs to elucidate whether follicle-stimulating hormone (FSH) can enhance this process and to evaluate the electrophysiological functionality of differentiated neural cells using the patch-clamp technique. Methods: OCC-NSPCs were differentiated towards the DA pathway during the neurosphere (NS) assay after two culture periods for cell expansion (CEP-1, CEP-2) with one of these media: M1 (positive control with epidermal growth factor, EGF, and fibroblast growth factor2, FGF2), M2 (control), and M3 (M2 with FSH, 50 ng/ml). Image analysis, morphometric evaluation, cell proliferation assays, and gene expression analysis of NSPC-specific transcripts were performed. After CEP-2, NS cells were cultured for 30 days in a serum-free medium containing Sonic-Hedgehog, FGF2, FGF8, and brain-derived neurotrophic factor (BDNF) for differentiation. At the end of culture, expression, and immunolocalization of GFAP, Olig2, NeuN, and tyrosine hydroxylase (TH) were analyzed in cells, along with patch-clamp recordings in differentiated neurons. Results: Cell pro-liferation and NS development were larger in OCC-NSPCs from groups M1 and M3 than in M2. Expression of NSPC-related transcripts was higher in M2; however, M1 and M3 cultures showed greater expression of differentiated markers NeuN, GFAP, Olig2, and TH. NeuN, GFAP, and TH were immunolocalized in differentiated cells and NS that were generated during differentiation. TH was localized in neural precursor cells, some neurons, core cells of small-, medium-, and large-sized NS, and in cells close to the outer cell layer of large NS, with greatest immunolocalization percentages in NS primed with FSH during CEP-1/2 (M3). Electrophysiological recordings revealed a major in-cidence of plateau potentials and a significant proportion of complete action potentials, reflecting successful functional neuronal differentiation. Conclusions: DA precursors and functional neurons can be successfully obtained after OCC-NSPCs-directed differentiation. FSH priming during the expansion period enhances the neurogenic potential of these cells towards the DA pathway. Future research will explore the eventual therapeutic use of these findings for neurodegenerative diseases.
dc.description.departmentSección Deptal. de Fisiología (Veterinaria)
dc.description.departmentSección Deptal. de Anatomía y Embriología (Veterinaria)
dc.description.departmentDepto. de Fisiología
dc.description.departmentSección Deptal. de Bioquímica y Biología Molecular (Veterinaria)
dc.description.facultyFac. de Veterinaria
dc.description.facultyFac. de Medicina
dc.description.refereedTRUE
dc.description.sponsorshipUniversidad Complutense de Madrid
dc.description.sponsorshipBanco Santander
dc.description.statuspub
dc.identifier.citationGonzález-Gil A, Rojo C, Ramírez E, Martín R, Suárez-Pinilla AS, Ovalle S, Ramos-Ruiz R, Picazo RA. Proneurogenic actions of FSH during directed differentiation of neural stem and progenitor cells from ovarian cortical cells towards the dopaminergic pathway. Biomedicines. 2025;13:1560. doi:10.3390/biomedicines13071560
dc.identifier.doi10.3390/biomedicines13071560
dc.identifier.essn2227-9059
dc.identifier.officialurlhttps://doi.org/10.3390/biomedicines13071560
dc.identifier.urihttps://hdl.handle.net/20.500.14352/122692
dc.issue.number7
dc.journal.titleBiomedicines
dc.language.isoeng
dc.page.final1585
dc.page.initial1560
dc.publisherMDPI
dc.relation.projectIDPR41/17-21020
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.cdu611.013.9
dc.subject.keywordFSH
dc.subject.keywordNeurogenesis
dc.subject.keywordDopaminergic neuron
dc.subject.keywordNeural stem and progenitor cells
dc.subject.keywordOvarian cortical cells
dc.subject.ucmCiencias Biomédicas
dc.subject.unesco32 Ciencias Médicas
dc.titleProneurogenic Actions of FSH During Directed Differentiation of Neural Stem and Progenitor Cells from Ovarian Cortical Cells Towards the Dopaminergic Pathway
dc.typejournal article
dc.type.hasVersionAM
dc.volume.number13
dspace.entity.typePublication
relation.isAuthorOfPublication0bd86cc7-2a7c-4d7f-ae70-3a119bd4c41e
relation.isAuthorOfPublication22fceef6-63ca-4a4b-a50a-c2d42fa6290a
relation.isAuthorOfPublicationcc43b025-0333-4623-bf95-b23dfeb9a76b
relation.isAuthorOfPublication81189690-7a6f-48e1-829d-6bc2877c4f08
relation.isAuthorOfPublicationba156e84-4d11-4bee-bd35-d1a59d2e0c44
relation.isAuthorOfPublication.latestForDiscovery0bd86cc7-2a7c-4d7f-ae70-3a119bd4c41e

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Proneurogenic Actions.pdf
Size:
6.23 MB
Format:
Adobe Portable Document Format

Collections